Lymphoma Trial, Recruiting NCT06794762 Sponsor: Karamanoğlu Mehmetbey University Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT06794762
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children between 7 and 18 years old
  • Children who have been diagnosed with ALL (Acute Lymphoblastic Leukaemia, a type of blood cancer)
  • Children who are currently in the maintenance phase of their chemotherapy treatment (a later, longer-term stage of treatment)
  • Children who do not have any active blood clots, active reduced blood flow to tissues, or unstable blood pressure or circulation at the time of the trial
  • Children who are not experiencing uncontrolled pain
  • Children who are able to understand and follow spoken instructions

Who may not be able to join:

  • Children who have received, or are currently receiving, radiation therapy to the head
  • Children who have any heart or blood vessel disease, or any breathing or lung condition, whether short-term or long-term
  • Children who have any current or ongoing problems with their bones, joints, or muscles
  • Children who have been diagnosed with a condition affecting movement or nerve control, or a genetic disorder
  • Children who have vision problems beyond simple eyesight correction (such as glasses or contact lenses)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +90 (543) 3518466

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Karamanoğlu Mehmetbey University
Registry
ClinicalTrials.gov
Start date
14 January 2025
Est. completion
1 February 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Timed Up and Go Test (TUG); Timed Up and Go Test (TUG); Sit-up Test; Sit-up Test; 6-Minute Walk Test; 6-Minute Walk Test; Balance Error Scoring System; Balance Error Scoring System; Pediatric Quality of Life Multidimensional Fatigue Scale; Pediatric Quality of Life Multidimensional Fatigue Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov